Nutritional Sciences

한국영양학회 (The Korean Nutrition Society)
권호 표지

The Effects of Green Tea Supplementation on Behavioral Changes, Striatal Dopamine Level, and Hepatic Antioxidant Parameters of Parkinson's Disease Model Rats

  • Kang, Min-Jeong (Departments of Food & Nutrition, College of Human Ecology, Hanyang University) ;
  • Lee, Sang-Sun (Departments of Food & Nutrition, College of Human Ecology, Hanyang University)
  • 발행 : 2006.05.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Green tea has attracted attention with respect to its potential for preventing and treating neurodegenerative disease. The neurotoxin, 6-hydroxydopamine (6-OHDA), was used to produce experimental Parkinson's disease (PD) model. The purpose of this study was to investigate the effects of green tea diet on behavioral changes, striatal dopamine content, and hepatic antioxidant parameters of PD model rats. In this study, we used male Sprague-Dawley rats weighing $200\sim220g$ and injected 6-OHDA into the right substantia nigra and medial forebrain bundle of the brain. The supply of green tea diet was started at 2 weeks before 6-OHDA lesion and continually supplied during 0, 2, and 4 weeks after 6-OHDA lesion (GT-0, GT-2, GT-4). Behavioral disturbance was measured by the stepping and d-amphetamine drug-induced rotation tests. Then, we assayed the striatal dopamine content and the hepatic malondialdehyde (MDA), hydrogen peroxide $(H_2O_2)$, and superoxide dismutase (SOD) activity. The percentage of lesioned forepaw to non-lesioned forepaw step scores was the highest in GT-4 group among all groups at both 3 and 4 weeks after 6-OHDA lesion. At 4 weeks after 6-OHDA lesion, the rotation score was the lowest in GT-2 group (p<0.05). However, increasing rate of the rotation score from 2 to 4 weeks after 6-OHDA lesion was the lowest in GT-4 group. The striatal dopamine content was not significantly different among four groups by green tea diet. The hepatic MDA level was the lowest in GT-4 group among four groups. The hepatic SOD activity was increased with the prolongation of green tea diet period These results suggest that green tea diet affects behavioral changes in rats of PD model. It seems that continuous green tea supplementation has an influence on the reduction of behavioral disturbance and the hepatic MDA level. Accordingly, continuous green tea supplementation was recommended for the prevention and treatment of PD. However, further studies are needed to investigate the mechanisms and efficacy of green tea in PD.

키워드

참고문헌

  1. Weinreb O, Mandel S, Amit T, Youdim MB. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's disease. J Nutr Biochem 15:506-516, 2004 https://doi.org/10.1016/j.jnutbio.2004.05.002
  2. Guo S, Bezard E, Zhao B. Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radic Biol Med 39:682-695, 2005 https://doi.org/10.1016/j.freeradbiomed.2005.04.022
  3. Pan T, Jankovic J, Le W. Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Drugs Aging 20:711-721, 2003 https://doi.org/10.2165/00002512-200320100-00001
  4. Yamamoto T, Lewis J, Wataha J, Dickinson D, Singh B, Bollag WB et al. Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects. J Pharmacal Exp Ther 308:317-323, 2004
  5. Kabuto H, Nishizawa M, Tada M, Higashio C, Shishibori T, Kohno M. Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increase superoxide scavenging activity in serum. Neurochem Res 30:325-332, 2005 https://doi.org/10.1007/s11064-005-2606-3
  6. Tsuboi K, Kimber TA, Shults CW. Calretinin-containing axons and neurons are resistant to an intrastriatal 6-hydroxydopamine lesion. Brain Res 866:55-64, 2000 https://doi.org/10.1016/S0006-8993(00)02219-8
  7. Rodriguez Diaz M, Abdala P, Barroso-Chinea P, Obeso J, Gonzalez-Hernandez T. Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease. Behav Brain Res 122:79-92, 2001 https://doi.org/10.1016/S0166-4328(01)00168-1
  8. Hermida-Ameijeiras A, Mendez-Alvarez E, Sanchez-Iglesias S, Sanmartin-Suarez C, Soto-Otero R. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions, Neurochem Int 45:103-116, 2004 https://doi.org/10.1016/j.neuint.2003.11.018
  9. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R et ai, Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease, Prog Neurobiol 65: 135-172, 2001 https://doi.org/10.1016/S0301-0082(01)00003-X
  10. Zaidi SM, Banu N. Antioxidant potential of vitamins A, E and C in modulating oxidative stress in rat brain. Clin Chim Acta 340:229-233, 2004 https://doi.org/10.1016/j.cccn.2003.11.003
  11. Yuan H, Sarre S, Ebinger G, Michotte Y. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease. Brain Res 1026:95-107, 2004 https://doi.org/10.1016/j.brainres.2004.08.015
  12. Iot Y, Fujita M, Shimada S, Watanabe Y, Okada T, Kusuoka H et at. Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models. Synapse 3 1:718-185, 1999
  13. Chen H, Zhang SM, Heman MA, Willett WC, Ascherio A. Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol 157:1007-1014, 2003 https://doi.org/10.1093/aje/kwg073
  14. Chang JW, Wachtel SR, Young D, Kang UJ. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions. Neuroscience 88:617-628, 1999 https://doi.org/10.1016/S0306-4522(98)00217-6
  15. Rodriguez M, Barroso-Chinea P, Abdala P, Obeso J, Gonzalez-Hernandez T. Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in Parkinson's disease. Exp Neurol 169:163-181, 2001 https://doi.org/10.1006/exnr.2000.7624
  16. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 4th ed. Academic Press, New York, 1998
  17. Olsson M, Nikkhah G, Bentlage C, Bjorklund A. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 15:3863-3875, 1995 https://doi.org/10.1523/JNEUROSCI.15-05-03863.1995
  18. Kirik D, Georgievska B, Rosenblad C, Bjorklund A. Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model Of Parkinson's disease. Eur J Neurosci 13:1589-1599, 2001 https://doi.org/10.1046/j.0953-816x.2001.01534.x
  19. Ossawska K, Wardas J, Kuter K, Nawak P, Dabrowska J, Bortel A et al. Influence of paraquat on dopaminergic transporter in the rat brain. Phamacol Rep 57:330-335, 2005
  20. Kang MJ, Ahn HS, Lee SS. Effects of polyunsaturated/saturated fatty acid ratio and antioxidant supplementation on hepatic TBARS and enzyme activities under the maintenance of dietary peroxidizability index value in young and adult rats. Ann Nutr Metab 49:304-311, 2005 https://doi.org/10.1159/000087334
  21. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 52:302-310, 1978 https://doi.org/10.1016/S0076-6879(78)52032-6
  22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976 https://doi.org/10.1016/0003-2697(76)90527-3
  23. Nobre Junior HV, Cunha GM, Maia FD, Oliveira RA, Moraes MO, Rao VS. Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephalic cell. Comp Biochem Physiol C Toxicol Pharmacol 136:175-180, 2003 https://doi.org/10.1016/S1532-0456(03)00198-4
  24. Komatsu M, Hiramatsu M. The efficacy of an antioxidant cocktail on lipid peroxide level and superoxide dismutase activity in aged rat brain and DNA damage in iran-induced epileptogenic faci. Toxicology 148:143-148, 2000 https://doi.org/10.1016/S0300-483X(00)00205-5
  25. Rice ME, Forman RE, Chen BT, Avshalumov MY, Cragg SJ, Drwe KL. Brain antioxidant reguIation in mammals and anoxia-tolerant reptiles: balanced for neuroprotection and neuromodulation. Comp Biochem Physiol C Toxical Pharmacol 133:515-525, 2002 https://doi.org/10.1016/S1532-0456(02)00116-3
  26. Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal 11:1-14, 1999 https://doi.org/10.1016/S0898-6568(98)00037-0
  27. Yokazawa T, Nakagawa T, Kitani K. Antioxidative activity of green tea polyphenol in cholesterol-fed rats. J Agric Food Chem 50:3549-3552, 2002 https://doi.org/10.1021/jf020029h
  28. Skrzydlewska E, Ostrowska J, Farbiszewski R, Michalak K. Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Phytomedicine 9:232-238, 2002 https://doi.org/10.1078/0944-7113-00119
  29. Crespy V, Williamson G. A review of the health effects of green tea catechins in in vivo animal models. J Nutr 134:3431S-3440S, 2004